RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+7.3%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$1.5B
AUM Growth
+$1.5B
(+5.6%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
31.43%
Holding
99
New
7
Increased
27
Reduced
26
Closed
7
Top Buys
| 1 |
Boston Scientific
BSX
|
$14.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$12.8M |
| 3 |
Danaher
DHR
|
$11.8M |
| 4 |
Inspire Medical Systems
INSP
|
$10.7M |
| 5 |
Align Technology
ALGN
|
$9.93M |
Top Sells
| 1 |
Abbott
ABT
|
$14.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
$10.6M |
| 3 |
Elevance Health
ELV
|
$10.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$8.92M |
| 5 |
Biogen
BIIB
|
$8.4M |
Sector Composition
| 1 | Healthcare | 97.82% |
| 2 | Industrials | 1.29% |
| 3 | Technology | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
26
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.7M | 1.38% |
150,000
+15,000
| +11% | +$2.07M |
|
27
Apellis Pharmaceuticals
APLS
$3.51B
| $20.6M | 1.37% |
430,000
-131,269
| -23% | -$6.29M |
|
|
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $20.3M | 1.35% |
390,000
-39,728
| -9% | -$2.07M |
|
29
Gilead Sciences
GILD
$140B
| $20.2M | 1.34% |
275,000
-25,000
| -8% | -$1.83M |
|
30
Guardant Health
GH
$8.11B
| $20M | 1.33% |
200,000
-5,000
| -2% | -$501K |
|
|
SGEN
31
DELISTED
Seagen Inc. Common Stock
SGEN
| $20M | 1.33% |
127,000
-8,000
| -6% | -$1.26M |
|
|
ABMD
32
DELISTED
Abiomed Inc
ABMD
| $18.8M | 1.25% |
52,000
-18,000
| -26% | -$6.52M |
|
33
Xencor
XNCR
$594M
| $18.3M | 1.22% |
450,000
-57,002
| -11% | -$2.32M |
|
|
AXNX
34
DELISTED
Axonics, Inc. Common Stock
AXNX
| $17.7M | 1.18% |
315,000
+25,000
| +9% | +$1.41M |
|
35
Tenet Healthcare
THC
$16.5B
| $17.2M | 1.14% |
210,000
+30,000
| +17% | +$2.46M |
|
36
Veeva Systems
VEEV
$44.4B
| $15.6M | 1.04% |
60,000
| – | – |
|
37
Privia Health
PRVA
$2.85B
| $15.4M | 1.02% |
580,000
+340,000
| +142% | +$9.01M |
|
38
HCA Healthcare
HCA
$95.4B
| $15.2M | 1.01% |
59,000
-16,000
| -21% | -$4.13M |
|
39
Intuitive Surgical
ISRG
$158B
| $14.5M | 0.97% |
40,000
-20,000
| -33% | -$7.27M |
|
|
40
Abbott
ABT
$230B
| $14.1M | 0.94% |
100,000
-106,000
| -51% | -$14.9M |
|
|
RCM
41
DELISTED
R1 RCM Inc. Common Stock
RCM
| $13.9M | 0.92% |
550,000
| – | – |
|
42
Nektar Therapeutics
NKTR
$543M
| $13.3M | 0.88% |
63,333
| – | – |
|
43
Edwards Lifesciences
EW
$47.7B
| $13.1M | 0.87% |
100,000
-5,000
| -5% | -$653K |
|
44
Neurocrine Biosciences
NBIX
$13.5B
| $12.8M | 0.85% |
151,100
+56,100
| +59% | +$4.75M |
|
|
45
Danaher
DHR
$143B
| $11.8M | 0.79% |
+40,608
| New | +$11.8M |
|
46
Teladoc Health
TDOC
$1.37B
| $11.8M | 0.78% |
125,000
-25,000
| -17% | -$2.36M |
|
47
Iovance Biotherapeutics
IOVA
$800M
| $11.7M | 0.77% |
600,000
+280,000
| +88% | +$5.44M |
|
48
Zimmer Biomet
ZBH
$20.8B
| $11.5M | 0.77% |
92,700
-30,900
| -25% | -$3.85M |
|
|
IMGN
49
DELISTED
Immunogen Inc
IMGN
| $11.2M | 0.74% |
1,500,000
+281,150
| +23% | +$2.09M |
|
|
50
Inspire Medical Systems
INSP
$2.53B
| $10.7M | 0.71% |
+46,373
| New | +$10.7M |
|